IL122502A0 - Medicaments for inducing oral tolerance in skin diseases presenting with t-cell mediated inflammation - Google Patents

Medicaments for inducing oral tolerance in skin diseases presenting with t-cell mediated inflammation

Info

Publication number
IL122502A0
IL122502A0 IL12250296A IL12250296A IL122502A0 IL 122502 A0 IL122502 A0 IL 122502A0 IL 12250296 A IL12250296 A IL 12250296A IL 12250296 A IL12250296 A IL 12250296A IL 122502 A0 IL122502 A0 IL 122502A0
Authority
IL
Israel
Prior art keywords
medicaments
skin diseases
cell mediated
oral tolerance
mediated inflammation
Prior art date
Application number
IL12250296A
Other languages
English (en)
Original Assignee
Autoimmune Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Autoimmune Inc filed Critical Autoimmune Inc
Publication of IL122502A0 publication Critical patent/IL122502A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL12250296A 1995-06-07 1996-06-05 Medicaments for inducing oral tolerance in skin diseases presenting with t-cell mediated inflammation IL122502A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48619095A 1995-06-07 1995-06-07

Publications (1)

Publication Number Publication Date
IL122502A0 true IL122502A0 (en) 1998-06-15

Family

ID=23930947

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12250296A IL122502A0 (en) 1995-06-07 1996-06-05 Medicaments for inducing oral tolerance in skin diseases presenting with t-cell mediated inflammation

Country Status (10)

Country Link
EP (1) EP0871478A1 (hu)
JP (1) JPH11507383A (hu)
KR (1) KR19990022556A (hu)
AU (1) AU6333796A (hu)
BR (1) BR9609014A (hu)
CA (1) CA2219457A1 (hu)
HU (1) HUP9901077A3 (hu)
IL (1) IL122502A0 (hu)
NO (1) NO975554D0 (hu)
WO (1) WO1996040232A1 (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999064066A1 (fr) * 1998-06-09 1999-12-16 Shionogi & Co., Ltd. Agents induisant une tolerance immunitaire et contenant de la keratine dure ou une substance ressemblant a la keratine
IL126447A (en) * 1998-10-04 2004-09-27 Vascular Biogenics Ltd An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis
KR102027451B1 (ko) 2012-11-02 2019-10-02 (주)아모레퍼시픽 마이크로 rna 및 이를 사용하는 스크리닝 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399347A (en) * 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen

Also Published As

Publication number Publication date
HUP9901077A2 (hu) 1999-07-28
WO1996040232A1 (en) 1996-12-19
EP0871478A1 (en) 1998-10-21
BR9609014A (pt) 1999-12-14
NO975554L (no) 1997-12-02
KR19990022556A (ko) 1999-03-25
HUP9901077A3 (en) 1999-11-29
JPH11507383A (ja) 1999-06-29
CA2219457A1 (en) 1996-12-19
NO975554D0 (no) 1997-12-02
AU6333796A (en) 1996-12-30

Similar Documents

Publication Publication Date Title
EP0759306A3 (en) Device for administering medication
EP0745401A3 (en) Medication inhaler
AU7286996A (en) Thermopile powered transdermal drug delivery device
IL124804A0 (en) Drug delivery device
ZA942804B (en) Oral drug delivery compositions and methods
AU6047498A (en) Method and system for interactive prescription and distribution of drugs in conducting medical studies
EP0767685A4 (en) STENT AND THERAPEUTIC ADMINISTRATION SYSTEM
AU7327294A (en) Methods and articles for administering drug to the oral cavity
HK1020523A1 (en) Uniform drug delivery therapy
GB9418064D0 (en) Medicament administration inhaler
HK1001375A1 (en) Use of acetylsalicylic acid in the manufacture of a drug for the treatment of skin injuries
IL120924A0 (en) Substituted 2-naphthoylguanidines process for their preparation their use as a medicament or diagnostic and medicaments containing them
HUP9900147A3 (en) Therapeutic agents and autoimmune diseases
IL116765A0 (en) On-line drug delivery system in extracorporeal therapy
HUP9901303A3 (en) A pharmaceutical composition for the treatment of autoimmune diseases
IL122502A0 (en) Medicaments for inducing oral tolerance in skin diseases presenting with t-cell mediated inflammation
IL115505A (en) Use of inhibitors of cyclooxygenase in the preparation of medicaments for the treatment of neurodegenerative diseases
IL112391A0 (en) A medicament in dosage unit form
IL120925A0 (en) Substituted 1-naphthoylguanidines process for their preparation their use as a medicament or diagnostic and medicaments containing them
GB9524942D0 (en) Drug therapy
EP0776666A3 (en) Analgesic and anti-inflammatory medication
ZA942881B (en) Quinolyl-dihydropyridine esters processes fot their preparation and their use in medicaments
ZA96784B (en) Medicine administering device for nasal cavities
AU6786796A (en) Transilluminator for use in human and veterinary medicine
AU6404698A (en) Treatment methods for obtaining therapeutic products and resulting products